Generic Medicine Production Rises 26% to Rs 4.06 Lakh Cr in Three Years, Parliament Informed We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
From Jaipur Pharmacy to Global Pharma Leader: Pioneer of Affordable TB Medicines, Macleods Founder Dr Rajendra Agarwal No More We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Eisai has agreed a deal to settle patent infringement litigation with generic drugmaker Torrent Pharma, preventing it from launching a copycat version of Eisai’s MSD-partnered cancer drug Lenvima in the US until 2030. The deal sets aside litigation being heard in a New Jersey district court, which alleged that Torrent’s marketing application for a generic…
Indian generic drug makers are not likely to face any immediate disruption from the 100% tariff imposed on “patented and branded” pharmaceutical imports announced by US President Donald Trump. However, the announcement posted on social media on Thursday, rattled pharma stocks in India amid lingering concerns that the scope could be expanded to include complex…
Generics company Zentiva is reported to be poised for a sale by current owner Advent International to US investment group GTCR – the second private equity handover of a European drugmaker this month. The Financial Times has said that Chicago-based GTCR has agreed a €4.1 billion (around $4.8 billion) deal to take control of the…
German pharma company Stada has said it may make another attempt to seek a public listing in the autumn, after delaying its plans earlier this year. Stada chief executive Peter Goldschmidt has said that the company will go for an initial public offering (IPO) in the coming months “provided the general conditions are right,” according…